Literature DB >> 31104993

First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors.

Yangxiong Li1, Jessi J Gardner1, Katherine R Fortney2, Inga V Leus3, Vincent Bonifay3, Helen I Zgurskaya3, Alexandre A Pletnev4, Sheng Zhang5, Zhong-Yin Zhang6, Gordon W Gribble4, Stanley M Spinola7, Adam S Duerfeldt8.   

Abstract

Genetic activation of the bacterial two-component signal transduction system, CpxRA, abolishes the virulence of a number of pathogens in human and murine infection models. Recently, 2,3,4,9-tetrahydro-1H-carbazol-1-amines were shown to activate the CpxRA system by inhibiting the phosphatase activity of CpxA. Herein we report the initial structure-activity relationships of this scaffold by focusing on three approaches 1) A-ring substitution, 2) B-ring deconstruction to provide N-arylated amino acid derivatives, and 3) C-ring elimination to give 2-ethylamino substituted indoles. These studies demonstrate that the A-ring is amenable to functionalization and provides a promising avenue for continued optimization of this chemotype. Further investigations revealed that the C-ring is not necessary for activity, although it likely provides conformational constraint that is beneficial to potency, and that the (R) stereochemistry is required at the primary amine. Simplification of the scaffold through deconstruction of the B-ring led to inactive compounds, highlighting the importance of the indole core. A new lead compound 26 was identified, which manifests a ∼30-fold improvement in CpxA phosphatase inhibition over the initial hit. Comparison of amino and des-amino derivatives in bacterial strains differing in membrane permeability and efflux capabilities demonstrate that the amine is required not only for target engagement but also for permeation and accumulation in Escherichia coli.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial; CpxRA; Drug discovery; Efflux; Medicinal chemistry; Permeability; Sensory kinase; Two-component system

Mesh:

Substances:

Year:  2019        PMID: 31104993      PMCID: PMC6594187          DOI: 10.1016/j.bmcl.2019.05.003

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  Involvement of the Cpx signal transduction pathway of E. coli in biofilm formation.

Authors:  C Dorel; O Vidal; C Prigent-Combaret; I Vallet; P Lejeune
Journal:  FEMS Microbiol Lett       Date:  1999-09-01       Impact factor: 2.742

2.  Genome-wide profiling of promoter recognition by the two-component response regulator CpxR-P in Escherichia coli.

Authors:  Peter De Wulf; Abigail M McGuire; Xueqiao Liu; Edmund C C Lin
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

3.  Trends in antimicrobial drug development: implications for the future.

Authors:  Brad Spellberg; John H Powers; Eric P Brass; Loren G Miller; John E Edwards
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

Review 4.  The global need for effective antibiotics: challenges and recent advances.

Authors:  Liselotte Diaz Högberg; Andreas Heddini; Otto Cars
Journal:  Trends Pharmacol Sci       Date:  2010-09-16       Impact factor: 14.819

5.  Development and validation of a high-throughput cell-based screen to identify activators of a bacterial two-component signal transduction system.

Authors:  Julia J van Rensburg; Kate R Fortney; Lan Chen; Andrew J Krieger; Bruno P Lima; Alan J Wolfe; Barry P Katz; Zhong-Yin Zhang; Stanley M Spinola
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

6.  Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.

Authors:  Lana Dbeibo; Julia J van Rensburg; Sara N Smith; Kate R Fortney; Dharanesh Gangaiah; Hongyu Gao; Juan Marzoa; Yunlong Liu; Harry L T Mobley; Stanley M Spinola
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 7.  Novel approaches to developing new antibiotics for bacterial infections.

Authors:  A R M Coates; Y Hu
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

Review 8.  Two-component signal transduction as potential drug targets in pathogenic bacteria.

Authors:  Yasuhiro Gotoh; Yoko Eguchi; Takafumi Watanabe; Sho Okamoto; Akihiro Doi; Ryutaro Utsumi
Journal:  Curr Opin Microbiol       Date:  2010-02-04       Impact factor: 7.934

9.  Breaking the Permeability Barrier of Escherichia coli by Controlled Hyperporination of the Outer Membrane.

Authors:  Ganesh Krishnamoorthy; David Wolloscheck; Jon W Weeks; Cameron Croft; Valentin V Rybenkov; Helen I Zgurskaya
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

10.  Transduction of envelope stress in Escherichia coli by the Cpx two-component system.

Authors:  T L Raivio; T J Silhavy
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

View more
  8 in total

Review 1.  Defining new chemical space for drug penetration into Gram-negative bacteria.

Authors:  Shibin Zhao; Justyna W Adamiak; Vincent Bonifay; Jitender Mehla; Helen I Zgurskaya; Derek S Tan
Journal:  Nat Chem Biol       Date:  2020-11-16       Impact factor: 15.040

2.  Compound Uptake into E. coli Can Be Facilitated by N-Alkyl Guanidiniums and Pyridiniums.

Authors:  Sarah J Perlmutter; Emily J Geddes; Bryon S Drown; Stephen E Motika; Myung Ryul Lee; Paul J Hergenrother
Journal:  ACS Infect Dis       Date:  2020-11-23       Impact factor: 5.084

3.  Drug Permeation against Efflux by Two Transporters.

Authors:  Paramita Saha; Samapan Sikdar; Ganesh Krishnamoorthy; Helen I Zgurskaya; Valentin V Rybenkov
Journal:  ACS Infect Dis       Date:  2020-02-25       Impact factor: 5.084

4.  Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch.

Authors:  Stephen E Motika; Rebecca J Ulrich; Emily J Geddes; Hyang Yeon Lee; Gee W Lau; Paul J Hergenrother
Journal:  J Am Chem Soc       Date:  2020-06-08       Impact factor: 15.419

Review 5.  Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria.

Authors:  Kristen A Muñoz; Paul J Hergenrother
Journal:  Acc Chem Res       Date:  2021-02-26       Impact factor: 22.384

Review 6.  An LC-MS/MS assay and complementary web-based tool to quantify and predict compound accumulation in E. coli.

Authors:  Emily J Geddes; Zhong Li; Paul J Hergenrother
Journal:  Nat Protoc       Date:  2021-09-03       Impact factor: 13.491

7.  Rationalizing the generation of broad spectrum antibiotics with the addition of a positive charge.

Authors:  Nandan Haloi; Archit Kumar Vasan; Emily J Geddes; Arjun Prasanna; Po-Chao Wen; William W Metcalf; Paul J Hergenrother; Emad Tajkhorshid
Journal:  Chem Sci       Date:  2021-10-14       Impact factor: 9.825

8.  CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.

Authors:  Kate R Fortney; Sara N Smith; Julia J van Rensburg; Julie A Brothwell; Jessi J Gardner; Barry P Katz; Nagib Ahsan; Adam S Duerfeldt; Harry L T Mobley; Stanley M Spinola
Journal:  Microbiol Spectr       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.